As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science.

The 2026 season of the Pharma.AI webinar series will showcase the ongoing AI revolution in life sciences, including the ...

Colin Talbot reviews a major new work on the global co-op movement, edited by Bruno Roelants, former director general of the ICA ...

TMR sticks, Hall effect triggers, a charging dock, and customisation options at this price point make the D10 stand out. You ...

At ‘The Space Between’ in Ojas Art gallery, there is a meditative calm. The ongoing show by Siddhartha Das and Chiara Nath ...

Silverado owners found a reliability top priority: the 8th VIN digit "E" confirms the 5.3L V8 lacks DFM hardware. This ...

Corporate Comms at Blue Star, on how shifting media dynamics and unpredictable demand patterns have prompted a rethink of the ...

For decades, Ford has been synonymous with stock car racing, but now one of its most loyal voices is raising eyebrows. When a ...

Stock Price Prediction, Deep Learning, LSTM, GRU, Attention Mechanism, Financial Time Series Share and Cite: Kirui, D. (2026) ...

Background The lack of skilled healthcare workers limits access to surgical care, with the greatest disparities in low- and ...

Objective Although socioeconomic status has been linked to various rheumatoid arthritis (RA)-related outcomes, evidence on ...